Schedule 13G

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C5fQbzMz/68oWYqX8dHW2bZC3vYrtCVRawo4XhzDTUocBICvesoKe3bmh2h/qZiL DEG+o5AAjzlZRSWpU8uy5g== 0001193125-06-029973.txt : 20060214 0001193125-06-029973.hdr.sgml : 20060214 20060214062925 ACCESSION NUMBER: 0001193125-06-029973 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060214 DATE AS OF CHANGE: 20060214 GROUP MEMBERS: DAVID M. MAUNEY, M.D. GROUP MEMBERS: JAY WATKINS GROUP MEMBERS: RICHARD M. FERRARI SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: FAVRILLE INC CENTRAL INDEX KEY: 0001285701 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330892797 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-81511 FILM NUMBER: 06606698 MAIL ADDRESS: STREET 1: 10421 PACIFIC CENTER COURT STREET 2: STE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DOTZLER FREDERICK J CENTRAL INDEX KEY: 0001306444 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: BUSINESS PHONE: 650-329-1999 MAIL ADDRESS: STREET 1: 1550 EL CAMINO REAL STREET 2: SUITE 150 CITY: MENLO PARK STATE: CA ZIP: 94025 SC 13G 1 dsc13g.htm SCHEDULE 13G Schedule 13G


OMB APPROVAL
OMB Number:		3235-0145
Expires:		January 31, 2006
Estimated average burden
hours per response . . . 11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. )*

Favrille, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

312088 40 4

(CUSIP Number)

December 31, 2005

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

SEC 1745 (1-06) 3340875-1

CUSIP No. 312088 40 4


1.		Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Frederick J. Dotzler
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ¨
3.		SEC Use Only
4.		Citizenship or Place of Organization United States of America

Number of

Beneficially by

Owned by

Each

Reporting

Person

With:

5. Sole Voting Power

6. Shared Voting Power

1,090,298 ⁽¹⁾

7. Sole Dispositive Power

8. Shared Dispositive Power

1,090,298 ⁽¹⁾


9.		Aggregate Amount Beneficially Owned by Each Reporting Person 1,090,298 ⁽¹⁾
10.		Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions).
11.		Percent of Class Represented by Amount in Row (9) 5.4%
12.		Type of Reporting Person (See Instructions) IN

⁽¹⁾

Includes 901,846 shares held by De Novo Ventures I, L.P. and 178,452 shares held by De Novo (Q) Ventures I, L.P. De Novo Management, L.L.C. is the sole general partner of De Novo Ventures I, L.P. and De Novo (Q) Ventures I, L.P. Frederick J. Dotzler, David M. Mauney, M.D., Richard M. Ferrari and Jay Watkins are managing directors of De Novo Management, L.L.C. and share voting and dispositive power with respect to shares held by De Novo Ventures I, L.P. and De Novo (Q) Ventures I, L.P. Also includes 10,000 shares held by the Dotzler Family Trust, of which Mr. Dotzler serves as a co-trustee. Mr. Dotzler disclaims beneficial ownership of the aforementioned shares except to the extent of his pecuniary interest therein.

Page 2 of 9 pages

CUSIP No. 312088 40 4


1.		Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). David M. Mauney, M.D.
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ¨
3.		SEC Use Only
4.		Citizenship or Place of Organization United States of America

Number of

Beneficially by

Owned by

Each

Reporting

Person

With:

5. Sole Voting Power

6. Shared Voting Power

1,080,298 ⁽²⁾

7. Sole Dispositive Power

8. Shared Dispositive Power

1,080,298 ⁽²⁾


9.		Aggregate Amount Beneficially Owned by Each Reporting Person 1,080,298 ⁽²⁾
10.		Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions).
11.		Percent of Class Represented by Amount in Row (9) 5.3%
12.		Type of Reporting Person (See Instructions) IN

⁽²⁾

Includes 901,846 shares held by De Novo Ventures I, L.P. and 178,452 shares held by De Novo (Q) Ventures I, L.P. De Novo Management, L.L.C. is the sole general partner of De Novo Ventures I, L.P. and De Novo (Q) Ventures I, L.P. Frederick J. Dotzler, David M. Mauney, M.D., Richard M. Ferrari and Jay Watkins are managing directors of De Novo Management, L.L.C. and share voting and dispositive power with respect to shares held by De Novo Ventures I, L.P. and De Novo (Q) Ventures I, L.P. Dr. Mauney disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest therein.

Page 3 of 9 pages

CUSIP No. 312088 40 4


1.		Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Richard M. Ferrari
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ¨
3.		SEC Use Only
4.		Citizenship or Place of Organization United States of America

Number of

Beneficially by

Owned by

Each

Reporting

Person

With:

5. Sole Voting Power

5,000

6. Shared Voting Power

1,080,298 ⁽³⁾

7. Sole Dispositive Power

5,000

8. Shared Dispositive Power

1,080,298 ⁽³⁾


9.		Aggregate Amount Beneficially Owned by Each Reporting Person 1,085,298 ⁽³⁾
10.		Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions).
11.		Percent of Class Represented by Amount in Row (9) 5.3%
12.		Type of Reporting Person (See Instructions) IN

⁽³⁾

Includes 901,846 shares held by De Novo Ventures I, L.P. and 178,452 shares held by De Novo (Q) Ventures I, L.P. De Novo Management, L.L.C. is the sole general partner of De Novo Ventures I, L.P. and De Novo (Q) Ventures I, L.P. Frederick J. Dotzler, David M. Mauney, M.D., Richard M. Ferrari and Jay Watkins are managing directors of De Novo Management, L.L.C. and share voting and dispositive power with respect to shares held by De Novo Ventures I, L.P. and De Novo (Q) Ventures I, L.P. Mr. Ferrari disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest therein.

Page 4 of 9 pages

CUSIP No. 312088 40 4


1.		Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Jay Watkins
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ¨
3.		SEC Use Only
4.		Citizenship or Place of Organization United States of America

Number of

Beneficially by

Owned by

Each

Reporting

Person

With:

5. Sole Voting Power

6. Shared Voting Power

1,080,298 ⁽⁴⁾

7. Sole Dispositive Power

8. Shared Dispositive Power

1,080,298 ⁽⁴⁾


9.		Aggregate Amount Beneficially Owned by Each Reporting Person 1,080,298 ⁽⁴⁾
10.		Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions).
11.		Percent of Class Represented by Amount in Row (9) 5.3%
12.		Type of Reporting Person (See Instructions) IN

⁽⁴⁾

Includes 901,846 shares held by De Novo Ventures I, L.P. and 178,452 shares held by De Novo (Q) Ventures I, L.P. De Novo Management, L.L.C. is the sole general partner of De Novo Ventures I, L.P. and De Novo (Q) Ventures I, L.P. Frederick J. Dotzler, David M. Mauney, M.D., Richard M. Ferrari and Jay Watkins are managing directors of De Novo Management, L.L.C. and share voting and dispositive power with respect to shares held by De Novo Ventures I, L.P. and De Novo (Q) Ventures I, L.P. Mr. Watkins disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest therein.

Page 5 of 9 pages

Item 1.

(a)

Name of Issuer

Favrille, Inc.

(b)

Address of Issuer’s Principal Executive Offices

10421 Pacific Center Court, Ste. 150, San Diego, CA 92121

Item 2.

(a)

Name of Person Filing

Frederick J. Dotzler

David M. Mauney, M.D.

Richard M. Ferrari

Jay Watkins

(b)

Address of Principal Business Office or, if none, Residence

c/o De Novo Ventures

1550 El Camino Real, Suite 150

Menlo Park, CA 94025

(c)

Citizenship

Frederick J. Dotzler

United States of America

David M. Mauney, M.D.

United States of America

Richard M. Ferrari

United States of America

Jay Watkins

United States of America

(d)

Title of Class of Securities

Common Stock, $0.001 par value per share

(e)

CUSIP Number

312088 40 4

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

Page 6 of 9 pages



Item 4.	Ownership

	(a)	Amount beneficially owned:



				Frederick J. Dotzler		1,090,298 ⁽¹⁾
				David M. Mauney, M.D.		1,080,298 ⁽²⁾
				Richard M. Ferrari		1,085,298 ⁽³⁾
				Jay Watkins		1,080,298 ⁽⁴⁾



		(b)		Percent of class:



				Frederick J. Dotzler		5.4%
				David M. Mauney, M.D.		5.3%
				Richard M. Ferrari		5.3%
				Jay Watkins		5.3%



(c)	Number of shares as to which the person has:

	(i)	Sole power to vote or to direct the vote:



						Frederick J. Dotzler		0
						David M. Mauney, M.D.		0
						Richard M. Ferrari		5,000
						Jay Watkins		0



				(ii)		Shared power to vote or to direct the vote:



						Frederick J. Dotzler		1,090,298⁽¹⁾
						David M. Mauney, M.D.		1,080,298 ⁽²⁾
						Richard M. Ferrari		1,080,298 ⁽³⁾
						Jay Watkins		1,080,298 ⁽⁴⁾



				(iii)		Sole power to dispose or to direct the disposition of:



						Frederick J. Dotzler		0
						David M. Mauney, M.D.		0
						Richard M. Ferrari		5,000
						Jay Watkins		0



				(iv)		Shared power to dispose or to direct the disposition of:



						Frederick J. Dotzler		1,090,298⁽¹⁾
						David M. Mauney, M.D.		1,080,298 ⁽²⁾
						Richard M. Ferrari		1,080,298 ⁽³⁾
						Jay Watkins		1,080,298 ⁽⁴⁾



Item 5.		Ownership of Five Percent or Less of a Class Not applicable.

Item 6.		Ownership of More than Five Percent on Behalf of Another Person Not applicable.

Item 7.		Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable.

Item 8.		Identification and Classification of Members of the Group Not applicable.

Item 9.		Notice of Dissolution of Group Not applicable.

Item 10.		Certification Not applicable.

Page 7 of 9 pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 13, 2006

/s/ Frederick J. Dotzler

Frederick J. Dotzler

/s/ David M. Mauney, M.D.

David M. Mauney, M.D.

/s/ Richard M. Ferrari

Richard M. Ferrari

/s/ Jay Watkins

Jay Watkins

Page 8 of 9 pages

Exhibit A

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including amendments thereto) relating to the Common Stock of Favrille, Inc. and further agree that this Joint Filing Agreement be included as an exhibit to such Schedule 13G. In evidence thereof, the undersigned hereby execute this Agreement as of February 13, 2006.

/s/ Frederick J. Dotzler

Frederick J. Dotzler

/s/ David M. Mauney, M.D.

David M. Mauney, M.D.

/s/ Richard M. Ferrari

Richard M. Ferrari

/s/ Jay Watkins

Jay Watkins

Page 9 of 9 pages

-----END PRIVACY-ENHANCED MESSAGE-----